TABS Blog

The CTA shifts enforcement from U.S. companies to foreign-owned entities operating in the U.S.

The difference between staying compliant and triggering U.S. tax residency often comes down to how days are counted, not how many.

The Inflation Reduction Act (IRA) reshaped how international companies evaluate U.S. expansion, capital planning, and long-term strategy.

FDA compliance is no longer a hurdle but a strategic advantage for U.S. market success.

Understanding state tax nexus is critical for European companies expanding to the U.S. Learn how physical presence impacts compliance.